+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2020

  • ID: 5189460
  • Report
  • October 2020
  • Region: Global
  • 140 Pages
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Aespira Ltd.
  • Creare LLC
  • Iconovo AB
  • Monash University
  • OtiTopic LLC
  • Sandoz International GmbH
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

The publisher's Medical Devices sector report, “Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2020“. Dry powder inhaler devices deliver medication to the lungs in the form of a dry powder.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Dry Powder Inhaler Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Dry Powder Inhaler Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Dry Powder Inhaler Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aespira Ltd.
  • Creare LLC
  • Iconovo AB
  • Monash University
  • OtiTopic LLC
  • Sandoz International GmbH

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Dry Powder Inhaler Devices Overview
3 Products under Development
3.1 Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
3.2 Dry Powder Inhaler Devices - Pipeline Products by Territory
3.3 Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path
3.4 Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date
3.5 Dry Powder Inhaler Devices - Ongoing Clinical Trials
4 Dry Powder Inhaler Devices - Pipeline Products under Development by Companies
4.1 Dry Powder Inhaler Devices Companies - Pipeline Products by Stage of Development
4.2 Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
5 Dry Powder Inhaler Devices Companies and Product Overview
5.1 Adamis Pharmaceuticals Corp Company Overview
5.1.1 Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
5.2 Advent Pharmaceuticals Pty Ltd Company Overview
5.2.1 Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Aespira Ltd. Company Overview
5.3.1 Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.4 AKELA Pharma Inc. (Inactive) Company Overview
5.4.1 AKELA Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.5 AstraZeneca Plc Company Overview
5.5.1 AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Bayer AG Company Overview
5.6.1 Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
5.7 Boehringer Ingelheim International GmbH Company Overview
5.7.1 Boehringer Ingelheim International GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.8 Circassia Group Plc Company Overview
5.8.1 Circassia Group Plc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Creare LLC Company Overview
5.9.1 Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
5.10 Eli Lilly and Co Company Overview
5.10.1 Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
5.11 GlaxoSmithKline Plc Company Overview
5.11.1 GlaxoSmithKline Plc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Hovione Technology Ltd Company Overview
5.12.1 Hovione Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 Iconovo AB Company Overview
5.13.1 Iconovo AB Pipeline Products & Ongoing Clinical Trials Overview
5.14 Liquidia Technologies Inc Company Overview
5.14.1 Liquidia Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Lupin Pharmaceuticals Inc Company Overview
5.15.1 Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 MannKind Corp Company Overview
5.16.1 MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview
5.17 Monash University Company Overview
5.17.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview
5.18 Nektar Therapeutics Company Overview
5.18.1 Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
5.19 Ology Bioservices Inc Company Overview
5.19.1 Ology Bioservices Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 OPKO Health Inc Company Overview
5.20.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 OtiTopic LLC Company Overview
5.21.1 OtiTopic LLC Pipeline Products & Ongoing Clinical Trials Overview
5.22 Pharmaxis Ltd Company Overview
5.22.1 Pharmaxis Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.23 Quench Medical Inc Company Overview
5.23.1 Quench Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 Respira Therapeutics Inc Company Overview
5.24.1 Respira Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.25 Sandoz International GmbH Company Overview
5.25.1 Sandoz International GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.26 Sheffield Hallam University Company Overview
5.26.1 Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview
5.27 Spyryx Biosciences Inc Company Overview
5.27.1 Spyryx Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 Sun Pharma Advanced Research Company Ltd Company Overview
5.28.1 Sun Pharma Advanced Research Company Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.29 University of Kansas Company Overview
5.29.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
5.30 University of Sydney Company Overview
5.30.1 University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
5.31 University of Texas Medical Branch at Galveston Company Overview
5.31.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
5.32 Vectura Group Plc Company Overview
5.32.1 Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview
5.33 Verona Pharma Plc Company Overview
5.33.1 Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Virginia Commonwealth University Company Overview
5.34.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview
6 Dry Powder Inhaler Devices- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer
List of Tables
Table 1: Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
Table 2: Dry Powder Inhaler Devices - Pipeline Products by Territory
Table 3: Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path
Table 4: Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date
Table 5: Dry Powder Inhaler Devices - Ongoing Clinical Trials
Table 6: Dry Powder Inhaler Devices Companies - Pipeline Products by Stage of Development
Table 7: Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
Table 8: Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Taper DPI - Product Status
Table 10: Taper DPI - Product Description
Table 11: Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 12: g60 Dry Powder Inhaler - Product Status
Table 13: g60 Dry Powder Inhaler - Product Description
Table 14: Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 15: resQhaler - Product Status
Table 16: resQhaler - Product Description
Table 17: AKELA Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Fentanyl TAIFUN Inhaler - Product Status
Table 19: Fentanyl TAIFUN Inhaler - Product Description
Table 20: AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Duaklir Genuair Metered Dose Inhaler - Product Status
Table 22: Duaklir Genuair Metered Dose Inhaler - Product Description
Table 23: Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Ciprofloxacin Dry Powder Inhaler - Product Status
Table 25: Ciprofloxacin Dry Powder Inhaler - Product Description
Table 26: Boehringer Ingelheim International GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Next Generation Respimat Inhaler - Product Status
Table 28: Next Generation Respimat Inhaler - Product Description
Table 29: Circassia Group Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Tiotropium bromide DPI - Product Status
Table 31: Tiotropium bromide DPI - Product Description
Table 32: Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Intranasal Dry Powder Inhaler - Product Status
Table 34: Intranasal Dry Powder Inhaler - Product Description
Table 35: Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Nasal Glucagon Delivery System - Product Status
Table 37: Nasal Glucagon Delivery System - Product Description
Table 38: GlaxoSmithKline Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Gemini Multi-Dose Combination Inhaler - Product Status
Table 40: Gemini Multi-Dose Combination Inhaler - Product Description
Table 41: Hovione Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Papillon DPI - Product Status
Table 43: Papillon DPI - Product Description
List of Figures
Figure 1: Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
Figure 2: Dry Powder Inhaler Devices - Pipeline Products by Territory
Figure 3: Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path
Figure 4: Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date
Figure 5: Dry Powder Inhaler Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Adamis Pharmaceuticals Corp
  • Advent Pharmaceuticals Pty Ltd
  • Aespira Ltd.
  • AKELA Pharma Inc. (Inactive)
  • AstraZeneca Plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Circassia Group Plc
  • Creare LLC
  • Eli Lilly and Co
  • GlaxoSmithKline Plc
  • Hovione Technology Ltd
  • Iconovo AB
  • Liquidia Technologies Inc
  • Lupin Pharmaceuticals Inc
  • MannKind Corp
  • Monash University
  • Nektar Therapeutics
  • Ology Bioservices Inc
  • OPKO Health Inc
  • OtiTopic LLC
  • Pharmaxis Ltd
  • Quench Medical Inc
  • Respira Therapeutics Inc
  • Sandoz International GmbH
  • Sheffield Hallam University
  • Spyryx Biosciences Inc
  • Sun Pharma Advanced Research Company Ltd
  • University of Kansas
  • University of Sydney
  • University of Texas Medical Branch at Galveston
  • Vectura Group Plc
  • Verona Pharma Plc
  • Virginia Commonwealth University
Note: Product cover images may vary from those shown